During a town hall in Wisconsin streamed live on YouTube on Monday, Elon Musk announced his brain-computer interface implant startup Neuralink will perform its first human implant of Blindsight, aimed at restoring vision in…
Continue Reading
Glaucoma, a leading cause of blindness, requires accurate early detection. We present an AI-based Glaucoma Screening (AI-GS) network comprising six lightweight deep learning models (total size: 110 MB) that analyze fundus images to identify…
Continue Reading
Glaucoma is the leading cause of irreversible blindness globally. Research indicates a disproportionate impact of glaucoma on racial and ethnic minorities. Existing deep learning models for glaucoma detection might not achieve equitable performance across…
Continue Reading
What You Should Know:
– Google Research is taking a significant step towards reducing preventable blindness by expanding access to its AI-powered diabetic retinopathy screening model in India and Thailand.
– This initiative aims to address…
Continue Reading
Google announced it is licensing its AI model focused on detecting diabetic retinopathy to partners in Thailand and India, two countries the tech giant says have a shortage of eye specialists. Google Research teams partnered…
Continue Reading
The main cause of corneal blindness worldwide is keratitis, especially the infectious form caused by bacteria, fungi, viruses, and Acanthamoeba. The key to effective management of infectious keratitis hinges on prompt and precise diagnosis….
Continue Reading
Visual impairments and blindness are major public health concerns globally. Effective eye disease screening aided by artificial intelligence (AI) is a promising countermeasure, although it is challenged by practical constraints such as poor image…
Continue Reading
What You Should Know: Verana Health® (Verana), a digital health company helping to revolutionize patient care and clinical research by unlocking the potential of real-world data, and the Foundation Fighting Blindness – the world’s leading organization committed…
Continue Reading
By Sara Heath
October 03, 2023 – A third of the 1.5 million Medicaid enrollees with opioid use disorder in 2021 did not receive medication to treat opioid use disorder (MOUD), with searing racial health disparities…
Continue Reading
Lucienne Marie Ide, M.D., PH.D., is the Founder & CEO of Rimidi While the pandemic has slowed, there appears to be no end in sight to the diabetes epidemic. The number of individuals diagnosed…
Continue Reading
